ASPH | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

626 results for “ASPH”

Trials

View all 337 →

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

180 participants · First posted Oct 27, 2015

SNS-301 Monotherapy in High Risk MDS and CMML

First posted Jan 3, 2020

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

300 participants · First posted Mar 31, 2016

Drugs

View all 145 →

ASPH-1106

ASPH-1132

ASPH-1047

Organizations

ASP CARES

United States

Alpha Metallurgical

United States

Ash Stevens LLC

United States

News

View all 140 →

Lantern Pharma Secures USPTO Notice of Allowance for Biomarker-Guided Patent on LP-184 in Multiple Solid Tumors

Sensei Biotherapeutics Abandons Lead Cancer Drug Solnerstotug Despite Promising Phase I Results

Vasopressin Shows Promise as Alternative to Epinephrine in Neonatal Resuscitation Study

Page 1 of 63